Analyzing Bioceres Crop Solutions (BIOX) and Its Peers

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) is one of 20 publicly-traded companies in the “Agricultural chemicals” industry, but how does it contrast to its competitors? We will compare Bioceres Crop Solutions to similar companies based on the strength of its analyst recommendations, institutional ownership, dividends, risk, earnings, valuation and profitability.

Risk and Volatility

Bioceres Crop Solutions has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, Bioceres Crop Solutions’ competitors have a beta of 1.15, meaning that their average stock price is 15% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Bioceres Crop Solutions and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bioceres Crop Solutions 0 0 3 0 3.00
Bioceres Crop Solutions Competitors 267 745 777 82 2.36

Bioceres Crop Solutions presently has a consensus target price of $25.33, suggesting a potential upside of 126.80%. As a group, “Agricultural chemicals” companies have a potential upside of 28.47%. Given Bioceres Crop Solutions’ stronger consensus rating and higher possible upside, equities analysts plainly believe Bioceres Crop Solutions is more favorable than its competitors.

Valuation & Earnings

This table compares Bioceres Crop Solutions and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Bioceres Crop Solutions $334.80 million -$7.20 million 55.85
Bioceres Crop Solutions Competitors $5.44 billion $1.09 billion 5.36

Bioceres Crop Solutions’ competitors have higher revenue and earnings than Bioceres Crop Solutions. Bioceres Crop Solutions is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Institutional & Insider Ownership

14.0% of Bioceres Crop Solutions shares are held by institutional investors. Comparatively, 37.8% of shares of all “Agricultural chemicals” companies are held by institutional investors. 2.3% of Bioceres Crop Solutions shares are held by insiders. Comparatively, 8.5% of shares of all “Agricultural chemicals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Bioceres Crop Solutions and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bioceres Crop Solutions 3.56% 5.37% 1.98%
Bioceres Crop Solutions Competitors -880.11% -18.06% -18.47%

Summary

Bioceres Crop Solutions beats its competitors on 7 of the 13 factors compared.

About Bioceres Crop Solutions

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates in three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Bolivia, Brazil, the United States, Paraguay, South Africa, France, Uruguay, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina.

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.